Aspirin Use Prevalence for Cardiovascular Disease Prevention Among U.S. Adults From 2012 to 2021

Ann Intern Med. 2024 Aug;177(8):1139-1141. doi: 10.7326/M24-0427. Epub 2024 Jun 25.

Authors

Mohak Gupta¹, Snigdha Gulati², Khurram Nasir³, Ashish Sarraju⁴

Affiliations

¹ Department of Medicine, Cleveland Clinic, Cleveland, Ohio.
² Department of Surgery, Creighton University, Phoenix, Arizona.
³ Division of Health Equity and Disparities Research, Center for Outcomes Research, Houston Methodist, Houston, Texas.
⁴ Section of Preventive Cardiology and Rehabilitation, Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio.

PMID: 38914002
DOI: 10.7326/M24-0427

No abstract available

Publication types

Letter

MeSH terms

Adult
Aged
Aspirin* / therapeutic use
Cardiovascular Diseases* / epidemiology
Cardiovascular Diseases* / prevention & control
Female
Humans
Male
Middle Aged
Platelet Aggregation Inhibitors / therapeutic use
Prevalence
United States / epidemiology

Substances

Aspirin
Platelet Aggregation Inhibitors